resazurin has been researched along with 4-anisyltetrazolium blue in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moravec, RA; Riss, TL | 1 |
| Cichon, I; Gonzalez Gonzalez, M; Kolaczkowska, E; Scislowska-Czarnecka, A | 1 |
2 other study(ies) available for resazurin and 4-anisyltetrazolium blue
| Article | Year |
|---|---|
Use of multiple assay endpoints to investigate the effects of incubation time, dose of toxin, and plating density in cell-based cytotoxicity assays.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Caspases; Cell Count; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Endpoint Determination; Humans; Indicators and Reagents; L-Lactate Dehydrogenase; Luminescent Measurements; Oxazines; Oxidation-Reduction; Spectrometry, Fluorescence; Tetrazolium Salts; Xanthenes | 2004 |
Challenges in 3D culturing of neutrophils: Assessment of cell viability.
Topics: Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Survival; HL-60 Cells; Humans; Neutrophils; Oxazines; Tetrazolium Salts; Tissue Scaffolds; Trypan Blue; Xanthenes | 2018 |